The Ontario Government has introduced the Ontario Workplace Naloxone Program created to help businesses to respond to opioid poisoning in the workplace.
The OCC is working with the Canadian Red Cross to get the word out to businesses in the province about the program that will help organizations to have up to 2 staff fully trained for free and receive a free naloxone kit. The new naloxone requirements under the Occupational Health and Safety Act (OHSA) will be effective from June 1, 2023.
Registration for the program is now open, and your organization can access free training for up to two employees per workplace and/or one free nasal naloxone kit per workplace.
We understand how challenging it can be to navigate new regulatory requirements. With funding from the Government of Ontario, Canadian Red Cross is offering limited-time support to assist eligible employers in meeting the new OHSA requirements. Through this program access to free training and kits is available to workplaces of any size from now until November 30, 2023.
Free training: ON Workplace Naloxone Program – First Aid for Opioid Poisoning Emergencies
-Online, self-directed course (45-60 minutes) available in English and French.
-Designed for Ontario workplaces to meet all requirements under the OHSA. Learners will gain skills and knowledge to prevent, recognize and respond to an opioid poisoning emergency, including how to administer nasal naloxone.
-Upon successful completion of the training by the registered workers, one free nasal spray naloxone kit will be automatically shipped to the registered workplace (employers do not need to submit a separate request for naloxone kits).
-Employers will be required to attest at time of registration that they have not previously registered for or received free training and/or a free naloxone kit through Ontario’s Workplace Naloxone Program for the workplace location requested.
-Employers with multiple eligible workplaces will need to complete a separate registration form for each location. Learn more about how employers can determine if they need to provide naloxone in the workplace.